Endotherapy devices market seen growing to $7.12 billion by 2030

The Business Research Company says the endotherapy devices market will rise from $4.87 billion in 2025 to $5.24 billion in 2026 and reach $7.12 billion by 2030. The report points to obesity, gastrointestinal disease, and broader adoption of minimally invasive procedures as key growth drivers, with North America leading and Asia-Pacific growing fastest.

Why it matters: - The endotherapy devices market is tied to the shift toward minimally invasive care, which can improve patient outcomes and healthcare efficiency. - Growing demand for these devices reflects rising need for gastrointestinal, obesity-related and other endoscopic treatments. - The market’s projected expansion signals more spending on advanced endoscopy tools, therapeutic procedures and AI-assisted imaging.

What happened: - The Business Research Company released a market study on the global endotherapy devices market. - The report estimates the market will grow from $4.87 billion in 2025 to $5.24 billion in 2026, a 7.6% CAGR. - The study projects the market will reach $7.12 billion by 2030, with an 8.0% CAGR during the forecast period. - The report also offers a free sample and the full market report.

The details: - Endotherapy devices are used during endoscopic procedures to diagnose, treat and manage conditions across gastrointestinal, colonoscopy, laparoscopy, anoscopy, arthroscopy and bronchoscopy cases. - The devices work with an endoscope, a flexible tube with a light and camera that lets physicians inspect internal organs and tissues. - Historical growth has been driven by rising gastrointestinal disorders, expansion of endoscopy infrastructure, wider use of minimally invasive surgical techniques, more sophisticated therapeutic endoscopes and demand for outpatient endoscopic procedures. - Looking ahead, growth drivers include investment in advanced endoscopy platforms, more therapeutic endoscopic interventions, precision-guided endotherapy, faster-recovery procedures and AI-assisted endoscopy technologies. - The report flags broader use of electrosurgical and ablation technologies, expanded therapeutic endoscopy applications and greater focus on precision and safety. - In 2025, North America is expected to hold the largest share of the market. - The Asia-Pacific region is expected to be the fastest-growing market in the coming years. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Obesity is emerging as a key demand driver because endotherapy devices can support weight-loss and appetite-suppression procedures with minimally invasive options. - World Obesity projected in March 2022 that the number of obese individuals will reach 892 million by 2025 and surpass 1 billion by 2030. - That forecast suggests a larger patient pool for endoscopic obesity treatments and related interventions. - The regional split points to a mature market in North America and faster adoption potential in Asia-Pacific as access and medical device investment expand.

What's next: - The market is expected to keep scaling as hospitals and outpatient providers adopt more advanced endoscopy systems. - Future growth will likely track continued uptake of therapeutic endoscopy, AI-assisted tools and precision-guided procedures. - The Business Research Company says its 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, hotspot infographics, key technologies and updated tables. - The company also provided contact details for expert follow-up and media outreach.